By using a machine learning approach, we found that the expression of the genes CSAD and SERINC3 discriminates between better and worse prognosis (low and high risk) for progression-free survival (PFS) of prostate cancer patients when they are stratified according to the Gleason score. This evidence concerns the gene CSAD and Familial prostate cancer.